Distribution of retinoic acid receptor-α immunoreactivity in the human hypothalamus

Neuroscience

Volumn 174, Issue , 2011, Pages 132-142

  Meng, Q Y ^a   Chen, X N ^a   Zhao, J ^a   Swaab, D F ^b   Zhou, J N ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

AVP; CRH; Hypothalamus; Immunohistochemisty; RAR

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; RETINOIC ACID RECEPTOR ALPHA; VASOPRESSIN;

ARCUATE NUCLEUS; ARTICLE; BRAIN CELL; BRAIN REGION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMILLARY BODY; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS;

AGED; AGED, 80 AND OVER; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; RECEPTORS, RETINOIC ACID; VASOPRESSINS;

EID: 78650926305     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.11.058     Document Type: Article

References (65)

1. Argiles A., Ootaka T., Hill P.A., Nikolic-Paterson D.J., Hutchinson P., Kraft N.E., Atkins R.C. Regulation of human renal adenocarcinoma cell growth by retinoic acid and its interactions with epidermal growth factor. Kidney Int 1994, 45:23-31.
2. Bao A.M., Fischer D.F., Wu Y.H., Hol E.M., Balesar R., Unmehopa U.A., Zhou J.N., Swaab D.F. A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol Psychiatry 2006, 11:567-576.
3. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
4. Barak Y., Wohl Y., Greenberg Y., Bar Dayan Y., Friedman T., Shoval G., Knobler H.Y. Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol 2005, 20:39-41.
5. Bhattacharya N., Dufour J.M., Vo M.N., Okita J., Okita R., Kim K.H. Differential effects of phthalates on the testis and the liver. Biol Reprod 2005, 72:745-754.
6. Bremner J.D. Does isotretinoin cause depression and suicide?. Psychopharmacol Bull 2003, 37:64-78.
7. Bremner J.D., McCaffery P. The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:315-331.
8. Chai Z., Yang L., Yu B., He Q., Li W.I., Zhou R., Zhang T., Zheng X., Xie J. p38 mitogen-activated protein kinase-dependent regulation of SRC-3 and involvement in retinoic acid receptor alpha signaling in embryonic cortical neurons. IUBMB Life 2009, 61:670-678.
9. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996, 10:940-954.
10. Chen W.-P., Libien J. Localization of retinoic acid Receptor RAR alpha in Adult Mouse Hippocampal Dentate Gyrus Neurons. FASEB J 2010, 24:lb236.
11. Chen X.N., Meng Q.Y., Bao A.M., Swaab D.F., Wang G.H., Zhou J.N. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders. Biol Psychiatry 2009, 66:832-839.
12. Cott A.D., Wisner K.L. Isotretinoin treatment of a woman with bipolar disorder. J Clin Psychiatry 1999, 60:407-408.
13. Darwiche N., Scita G., Jones C., Rutberg S., Greenwald E., Tennenbaum T., Collins S.J., De Luca L.M., Yuspa S.H. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression. Cancer Res 1996, 56:4942-4949.
14. Day R.M., Lee Y.H., Park A.M., Suzuki Y.J. Retinoic acid inhibits airway smooth muscle cell migration. Am J Respir Cell Mol Biol 2006, 34:695-703.
15. de Bree F.M., Burbach J.P. Heterologous biosynthesis and processing of preprovasopressin in Neuro2A neuroblastoma cells. Biochimie 1994, 76:315-319.
16. Dolle P., Ruberte E., Leroy P., Morriss-Kay G., Chambon P. Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 1990, 110:1133-1151.
17. Dufour J.M., Kim K.H. Cellular and subcellular localization of six retinoid receptors in rat testis during postnatal development: identification of potential heterodimeric receptors. Biol Reprod 1999, 61:1300-1308.
18. Fukunaka K., Saito T., Wataba K., Ashihara K., Ito E., Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol Hum Reprod 2001, 7:437-446.
19. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., De Lera A.R., Lotan R., Mangelsdorf D.J., Gronemeyer H. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006, 58:712-725.
20. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994, 15:61-79.
21. Giguere V., Ong E.S., Segui P., Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature 1987, 330:624-629.
22. Halevy O., Lerman O. Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-alpha. J Cell Physiol 1993, 154:566-572.
23. Hara I., Taguchi I., Miyake H., Hara S., Gotoh A., Kamidono S. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma. Int J Oncol 2001, 19:959-962.
24. Hatoum A., El-Sabban M.E., Khoury J., Yuspa S.H., Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001, 22:1955-1963.
25. Hawthorn J., Ang V.T., Jenkins J.S. Effects of lesions in the hypothalamic paraventricular, supraoptic and suprachiasmatic nuclei on vasopressin and oxytocin in rat brain and spinal cord. Brain Res 1985, 346:51-57.
26. Hofman M.A., Swaab D.F. Seasonal changes in the suprachiasmatic nucleus of man. Neurosci Lett 1992, 139:257-260.
27. Hofman M.A., Swaab D.F. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 1993, 8:283-295.
28. Hou-Yu A., Ehrlich P.H., Valiquette G., Engelhardt D.L., Sawyer W.H., Nilaver G., Zimmerman E.A. A monoclonal antibody to vasopressin: preparation, characterization, and application in immunocytochemistry. J Histochem Cytochem 1982, 30:1249-1260.
29. Hull P.R., D'Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 2003, 4:493-505.
30. Jick S.S., Kremers H.M., Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000, 136:1231-1236.
31. Kasckow J.W., Han J.H., Parkes D.G., Mulchahey J.J., Owens M.J., Risby E.D., Fisher J., Nemeroff C.B. Regulation of corticotropin-releasing factor secretion and synthesis in the human neuroblastoma clones-BE(2)-M17 and BE(2)-C. J Neuroendocrinol 1995, 7:461-466.
32. Kern J., Schrage K., Koopmans G.C., Joosten E.A., McCaffery P., Mey J. Characterization of retinaldehyde dehydrogenase-2 induction in NG2-positive glia after spinal cord contusion injury. Int J Dev Neurosci 2007, 25:7-16.
33. Krezel W., Kastner P., Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999, 89:1291-1300.
34. Labrie F., Giguere V., Proulx L., Lefevre G. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion. J Steroid Biochem 1984, 20:153-160.
35. Lane M.A., Bailey S.J. Role of retinoid signalling in the adult brain. Prog Neurobiol 2005, 75:275-293.
36. Leroy P., Krust A., Zelent A., Mendelsohn C., Garnier J.M., Kastner P., Dierich A., Chambon P. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991, 10:59-69.
37. Liebler S., Uberschar B., Kubert H., Brems S., Schnitger A., Tsukada M., Zouboulis C.C., Ritz E., Wagner J. The renal retinoid system: time-dependent activation in experimental glomerulonephritis. Am J Physiol Renal Physiol 2004, 286:F458-F465.
38. Masia S., Alvarez S., de Lera A.R., Barettino D. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 2007, 21:2391-2402.
39. McCaffery P., Zhang J., Crandall J.E. Retinoic acid signaling and function in the adult hippocampus. J Neurobiol 2006, 66:780-791.
40. Mendelsohn C., Batourina E., Fung S., Gilbert T., Dodd J. Stromal cells mediate retinoid-dependent functions essential for renal development. Development 1999, 126:1139-1148.
41. Mey J., McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 2004, 10:409-421.
42. Neuville P., Yan Z., Gidlof A., Pepper M.S., Hansson G.K., Gabbiani G., Sirsjo A. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol 1999, 19:1430-1436.
43. Oseto S., Moriyama T., Kawada N., Nagatoya K., Takeji M., Ando A., Yamamoto T., Imai E., Hori M. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 2003, 64:1241-1252.
44. Petkovich M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987, 330:444-450.
45. Poon M.M., Chen L. Retinoic acid-gated sequence-specific translational control by RARalpha. Proc Natl Acad Sci U S A 2008, 105:20303-20308.
46. Raadsheer F.C., Sluiter A.A., Ravid R., Tilders F.J., Swaab D.F. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 1993, 615:50-62.
47. Ramkumar T., Adler S. A requirement for the POU transcription factor, Brn-2, in corticotropin-releasing hormone expression in a neuronal cell line. Mol Endocrinol 1999, 13:1237-1248.
48. Rochette-Egly C., Germain P. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal 2009, 7:e005.
49. Ross A.W., Bell L.M., Littlewood P.A., Mercer J.G., Barrett P., Morgan P.J. Temporal changes in gene expression in the arcuate nucleus precede seasonal responses in adiposity and reproduction. Endocrinology 2005, 146:1940-1947.
50. Ross A.W., Webster C.A., Mercer J.G., Moar K.M., Ebling F.J., Schuhler S., Barrett P., Morgan P.J. Photoperiodic regulation of hypothalamic retinoid signaling: association of retinoid X receptor gamma with body weight. Endocrinology 2004, 145:13-20.
51. Ruberte E., Dolle P., Chambon P., Morriss-Kay G. Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 1991, 111:45-60.
52. Schaier M., Liebler S., Schade K., Shimizu F., Kawachi H., Grone H.J., Chandraratna R., Ritz E., Wagner J. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med 2004, 82:116-125.
53. Schrage K., Koopmans G., Joosten E.A., Mey J. Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur J Neurosci 2006, 23:285-295.
54. Shearer K.D., Goodman T.H., Ross A.W., Reilly L., Morgan P.J., McCaffery P.J. Photoperiodic regulation of retinoic acid signaling in the hypothalamus. J Neurochem 2010, 112:246-257.
55. Shirai H., Oishi K., Ishida N. Bidirectional CLOCK/BMAL1-dependent circadian gene regulation by retinoic acid in vitro. Biochem Biophys Res Commun 2006, 351:387-391.
56. Strahan J.E., Raimer S. Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol 2006, 45:789-799.
57. Swaab D.F. Human hypothalamus: basic and clinical aspects, Part I. Nuclei of the human hypothalamus 2003, Elsevier, Amsterdam.
58. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005, 4:141-194.
59. Thorn N.A. Antidiuretic hormones synthesis, release, and action under normal and pathological circumstances. Adv Metab Disord 1970, 4:39-73.
60. Torma H., Karlsson T., Michaelsson G., Rollman O., Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol 2000, 80:4-9.
61. van Oers J.W., Tilders J.H., Berkenbosch F. Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor. Endocrinology 1989, 124:1239-1246.
62. Wu Y.H., Zhou J.N., Balesar R., Unmehopa U., Bao A., Jockers R., Van Heerikhuize J., Swaab D.F. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J Comp Neurol 2006, 499:897-910.
63. Yamauchi T., Ishibashi A., Shikata K., Tokuhara N., Seino K., Kobayashi S., Nagai M. Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice. J Pharmacol Exp Ther 2005, 312:938-944.
64. Zetterstrom R.H., Lindqvist E., Mata de Urquiza A., Tomac A., Eriksson U., Perlmann T., Olson L. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 1999, 11:407-416.
65. Zhong J.C., Huang D.Y., Yang Y.M., Li Y.F., Liu G.F., Song X.H., Du K. Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 2004, 44:907-912.